Dopaminergic (DA) neurons of mouse and rat retinas are of the interplexiform subtype (DA-IPC), i.e., they send processes distally toward the outer retina, exhibiting numerous varicosities along their course. The primary question we addressed was whether distally located DA-IPC varicosities, identified by tyrosine hydroxylase (TH) immunoreactivity, had the characteristic presynaptic proteins associated with calcium-dependent vesicular release of neurotransmitter. We found that TH immunoreactive varicosities in the outer retina possessed vesicular monoamine transporter 2 and vesicular GABA transporter, but they lacked immunostaining for any of nine subtypes of voltage-dependent calcium channel. Immunoreactivity for other channels that may permit calcium influx such as certain ionotropic glutamate receptors and canonical transient receptor potential channels (TRPCs) was similarly absent, although DA-IPC varicosities did show ryanodine receptor immunoreactivity, indicating the presence of intracellular calcium stores. The synaptic vesicle proteins sv2a and sv2b and certain other proteins associated with the presynaptic membrane were absent from DA-IPC varicosities, but the vesicular SNARE protein, vamp2, was present in a fraction of those varicosities. We identified a presumed second class of IPC that is GABAergic but not dopaminergic. Outer retinal varicosities of this putative GABAergic IPC did colocalize synaptic vesicle protein 2a, suggesting they possessed a conventional vesicular release mechanism.
Pubmed ID: 18615559 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software package for analysis of microarray images. Microarray spot detection and characterization software package which extracts numerical information from cDNA microarrays.
View all literature mentionsThis monoclonal targets D1 Dopamine Receptor
View all literature mentionsThis unknown targets CACNA1A (CaV2.1) Channel
View all literature mentionsThis unknown targets CACNA1B (CaV2.2) Channel
View all literature mentionsThis unknown targets CaV2.3 (CACNA1E) Channel
View all literature mentionsThis polyclonal targets Glutamate receptor 1
View all literature mentionsThis polyclonal targets TRPC3 (Transient Receptor Potential-Like Channel 3, TRP-3)
View all literature mentionsThis polyclonal targets Transient Receptor Potential Channel 7 pain
View all literature mentionsThis monoclonal targets SERCA2 ATPase
View all literature mentionsThis monoclonal targets RyR1
View all literature mentionsThis polyclonal targets TRPC1 (Transient Receptor Potential-Like Channel 1, TRP-1)
View all literature mentionsThis unknown targets Calcium Channel (alpha1C Subunit) (L-type of Voltage-gated Ca2+ Channel)
View all literature mentionsThis unknown targets Calcium Channel (alpha1D Subunit) (L-type of Voltage-gated Ca2+ Channel)
View all literature mentionsThis polyclonal targets Tyrosine Hydroxylase
View all literature mentionsThis monoclonal targets Syntaxin
View all literature mentionsThis monoclonal targets Sodium Channel, Pan
View all literature mentionsThis polyclonal targets Synaptobrevin 1
View all literature mentionsThis monoclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis polyclonal targets Glutamate Receptor 2 & 3
View all literature mentionsThis polyclonal targets Glutamate Receptor 4
View all literature mentionsThis polyclonal targets GAT-3
View all literature mentionsThis polyclonal targets GABA Transporter-1 C-terminus (a.a. 588-599)
View all literature mentionsThis polyclonal targets Dopamine Transporter (DAT)
View all literature mentionsThis polyclonal targets TRPC4 (Transient Receptor Potential-Like Channel 4, TRP-4)
View all literature mentionsThis monoclonal targets IP3 Receptor, Types 1-3
View all literature mentions